278 related articles for article (PubMed ID: 31649817)
1. Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.
Baier C; Beck M; Panagiota V; Lueck C; Kharazipour D; Hintze SC; Bollin R; Ebadi E; Ziesing S; Eder M; Bange FC; Beutel G
Antimicrob Resist Infect Control; 2019; 8():160. PubMed ID: 31649817
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
[TBL] [Abstract][Full Text] [Related]
3. Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety.
Mularoni A; Cona A; Campanella M; Barbera F; Medaglia AA; Cervo A; Cuscino N; Di Mento G; Graziano E; El Jalbout JD; Alduino R; Tuzzolino F; Monaco F; Cascio A; Peghin M; Gruttadauria S; Bertani A; Conaldi PG; Mikulska M; Grossi PA
Am J Transplant; 2024 Jun; 24(6):1046-1056. PubMed ID: 38342183
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of carbapenem-resistant Gram-negative infections globally.
Brink AJ
Curr Opin Infect Dis; 2019 Dec; 32(6):609-616. PubMed ID: 31567571
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
[TBL] [Abstract][Full Text] [Related]
7. The role of carbapenem-resistant pathogens in cSSTI and how to manage them.
Del Giacomo P; Losito AR; Tumbarello M
Curr Opin Infect Dis; 2019 Apr; 32(2):113-122. PubMed ID: 30648994
[TBL] [Abstract][Full Text] [Related]
8. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
10. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
Maina JW; Mutua JM; Musyoki AM
BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
[TBL] [Abstract][Full Text] [Related]
12. Colonization and Infection With Extensively Drug Resistant Gram-Negative Bacteria in Liver Transplant Recipients.
Massa E; Michailidou E; Agapakis D; Papadopoulos S; Tholioti T; Aleuroudis I; Bargiota T; Passakiotou M; Daoudaki M; Antoniadis N; Imvrios G; Iosifidis E; Vagdatli E; Roilides E; Vasilakos D; Fouzas I; Mouloudi E
Transplant Proc; 2019 Mar; 51(2):454-456. PubMed ID: 30879565
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy for carbapenem-resistant Gram-negative bacteria.
Paul M; Carmeli Y; Durante-Mangoni E; Mouton JW; Tacconelli E; Theuretzbacher U; Mussini C; Leibovici L
J Antimicrob Chemother; 2014 Sep; 69(9):2305-9. PubMed ID: 24872346
[TBL] [Abstract][Full Text] [Related]
14. Surveillance culture for multidrug-resistant gram-negative bacteria: Performance in liver transplant recipients.
Freire MP; Villela Soares Oshiro IC; Bonazzi PR; Pierrotti LC; de Oliveira LM; Machado AS; Van Der Heijdenn IM; Rossi F; Costa SF; Carneiro D'Albuquerque LA; Abdala E
Am J Infect Control; 2017 Mar; 45(3):e40-e44. PubMed ID: 28254253
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem-Resistant Gram Negative Bacilli Are Predominantly Multidrug or Pan-Drug Resistant.
Kannian P; Mahanathi P; Ashwini V; Vaishnavi M; Priya C
Microb Drug Resist; 2021 Aug; 27(8):1057-1062. PubMed ID: 33417816
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study.
Hu H; Wang Y; Sun J; Wang Y; Zhou J; Shi Q; Han X; Jiang Y; Wu D; Huang X; Yu Y
Microbiol Spectr; 2024 Jun; ():e0429923. PubMed ID: 38847538
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Papas V; Pitsiolis T; Tsakris A; Nanas S; Roussos C
Intensive Care Med; 2013 Jul; 39(7):1253-61. PubMed ID: 23604133
[TBL] [Abstract][Full Text] [Related]
19. The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.
Savoldi A; Carrara E; Piddock LJV; Franceschi F; Ellis S; Chiamenti M; Bragantini D; Righi E; Tacconelli E
BMC Infect Dis; 2021 Jun; 21(1):545. PubMed ID: 34107899
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
